Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals
- PMID: 25124145
- DOI: 10.1016/j.molimm.2014.06.038
Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals
Abstract
Intravenous injection of a variety of nanotechnology enhanced (liposomal, micellar, polymer-conjugated) and protein-based (antibodies, enzymes) drugs can lead to hypersensitivity reactions (HSRs), also known as infusion, or anaphylactoid reactions. The molecular mechanism of mild to severe allergy symptoms may differ from case to case and is mostly not known, however, in many cases a major cause, or contributing factor is activation of the complement (C) system. The clinical relevance of C activation-related HSRs, a non-IgE-mediated pseudoallergy (CARPA), lies in its unpredictability and occasional lethal outcome. Accordingly, there is an unmet medical need to develop laboratory assays and animal models that quantitate CARPA. This review provides basic information on CARPA; a short history, issues of nomenclature, incidence, classification of reactogenic drugs and symptoms, and the mechanisms of C activation via different pathways. It is pointed out that anaphylatoxin-induced mast cell release may not entirely explain the severe reactions; a "second hit" on allergy mediating cells may also contribute. In addressing the increasing requirements for CARPA testing, the review evaluates the available assays and animal models, and proposes a possible algorithm for the screening of reactogenic drugs and hypersensitive patients. Finally, an analogy is proposed between CARPA and the classic stress reaction, suggesting that CARPA represents a "blood stress" reaction, a systemic fight of the body against harmful biological and chemical agents via the anaphylatoxin/mast-cell/circulatory system axis, in analogy to the body's fight of physical and emotional stress via the hypothalamo/pituitary/adrenal axis. In both cases the response to a broad variety of noxious effects are funneled into a uniform pattern of physiological changes.
Keywords: Allergy; Anaphylatoxins; Anaphylaxis; CARPA; Inflammatory mediators; Pseudoallergy.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention.Adv Drug Deliv Rev. 2011 Sep 16;63(12):1020-30. doi: 10.1016/j.addr.2011.06.017. Epub 2011 Jul 14. Adv Drug Deliv Rev. 2011. PMID: 21787819 Review.
-
Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.Crit Rev Ther Drug Carrier Syst. 2001;18(6):567-606. Crit Rev Ther Drug Carrier Syst. 2001. PMID: 11789676 Review.
-
A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines.Adv Drug Deliv Rev. 2012 Dec;64(15):1706-16. doi: 10.1016/j.addr.2012.07.005. Epub 2012 Jul 20. Adv Drug Deliv Rev. 2012. PMID: 22820530 Review.
-
Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity.Toxicology. 2005 Dec 15;216(2-3):106-21. doi: 10.1016/j.tox.2005.07.023. Epub 2005 Sep 2. Toxicology. 2005. PMID: 16140450 Review.
-
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.J Control Release. 2014 Dec 10;195:2-10. doi: 10.1016/j.jconrel.2014.08.009. Epub 2014 Aug 19. J Control Release. 2014. PMID: 25148822
Cited by
-
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation.Allergy. 2021 Nov;76(11):3307-3313. doi: 10.1111/all.14794. Epub 2021 Jun 17. Allergy. 2021. PMID: 33657648 Free PMC article. Review.
-
Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective.Viruses. 2021 Mar 5;13(3):418. doi: 10.3390/v13030418. Viruses. 2021. PMID: 33807839 Free PMC article. Review.
-
Recent advances in mechanical force-responsive drug delivery systems.Nanoscale Adv. 2022 Jul 18;4(17):3462-3478. doi: 10.1039/d2na00420h. eCollection 2022 Aug 23. Nanoscale Adv. 2022. PMID: 36134346 Free PMC article. Review.
-
New milestones ahead in complement-targeted therapy.Semin Immunol. 2016 Jun;28(3):208-22. doi: 10.1016/j.smim.2016.06.001. Epub 2016 Jun 16. Semin Immunol. 2016. PMID: 27321574 Free PMC article. Review.
-
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management.BioDrugs. 2022 Jul;36(4):443-458. doi: 10.1007/s40259-022-00536-8. Epub 2022 Jun 13. BioDrugs. 2022. PMID: 35696066 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical